INVEX THERAPEUTICS LTD

Dissolved London

Research and experimental development on biotechnology

1 employees website.com
Research and experimental development on biotechnology
I

INVEX THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 12 Dec 2019 Dissolved London, England 1 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 5 Aug 2025 Next due 31 Mar 2027 10 months remaining
Confirmation Submitted 20 Dec 2024 Next due 25 Dec 2025 5 months overdue
Net assets £11K £5M 2025 year on year
Total assets £15K £797K 2025 year on year
Total Liabilities £4K £6M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Eccleston Yards 25 Eccleston Place London SW1W 9NF England

Website

www.example.com

Full company profile for INVEX THERAPEUTICS LTD (12361382), a dissolved company based in London, England. Incorporated 12 Dec 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2020–2025)

Cash in Bank

£13.38k

Decreased by £621.77k (-98%)

Net Assets

£11.30k

Increased by £5.35M (+100%)

Total Liabilities

£3.83k

Decreased by £6.15M (-100%)

Turnover

N/A

Employees

1

Decreased by 3 (-75%)

Debt Ratio

25%

Decreased by 732 (-97%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Eastman, Anthony Neville ChisholmDirectorAustralianUnited Kingdom5110 Jul 2023Active
Oakwood Corporate Secretary LimitedCorporate-secretaryUnknownUnknown12 Dec 2019Active

Shareholders

Shareholders (1)

Invex Therapeutics Ltd
100.0%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Feb 2026GazetteGazette Dissolved Voluntary
5 Aug 2025AccountsAnnual accounts made up to 30 Jun 2025
20 Dec 2024Confirmation StatementConfirmation statement made on 11 Dec 2024 with no updates
22 Oct 2024AccountsAnnual accounts made up to 30 Jun 2024
12 Dec 2023Confirmation StatementConfirmation statement made on 11 Dec 2023 with no updates
24 Feb 2026 Gazette

Gazette Dissolved Voluntary

5 Aug 2025 Accounts

Annual accounts made up to 30 Jun 2025

20 Dec 2024 Confirmation Statement

Confirmation statement made on 11 Dec 2024 with no updates

22 Oct 2024 Accounts

Annual accounts made up to 30 Jun 2024

12 Dec 2023 Confirmation Statement

Confirmation statement made on 11 Dec 2023 with no updates

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

2 months ago on 24 Feb 2026

Annual accounts made up to 30 Jun 2025

9 months ago on 5 Aug 2025

Confirmation statement made on 11 Dec 2024 with no updates

1 years ago on 20 Dec 2024

Annual accounts made up to 30 Jun 2024

1 years ago on 22 Oct 2024

Confirmation statement made on 11 Dec 2023 with no updates

2 years ago on 12 Dec 2023